Fidelity Investments’s Mirum Pharmaceuticals MIRM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.02M | Buy |
59,441
+5,114
| +9% | +$260K | ﹤0.01% | 2341 |
|
|
2025
Q1 | $2.45M | Buy |
54,327
+49,512
| +1,028% | +$2.23M | ﹤0.01% | 2382 |
|
|
2024
Q4 | $199K | Buy |
4,815
+3,498
| +266% | +$145K | ﹤0.01% | 3267 |
|
|
2024
Q3 | $51.4K | Buy |
1,317
+431
| +49% | +$16.8K | ﹤0.01% | 3767 |
|
|
2024
Q2 | $30.3K | Sell |
886
-19,435
| -96% | -$665K | ﹤0.01% | 3865 |
|
|
2024
Q1 | $510K | Sell |
20,321
-456
| -2% | -$11.5K | ﹤0.01% | 2708 |
|
|
2023
Q4 | $613K | Buy |
20,777
+19,204
| +1,221% | +$567K | ﹤0.01% | 2615 |
|
|
2023
Q3 | $49.7K | Sell |
1,573
-2,169
| -58% | -$68.5K | ﹤0.01% | 3371 |
|
|
2023
Q2 | $96.8K | Buy |
3,742
+2,723
| +267% | +$70.4K | ﹤0.01% | 3175 |
|
|
2023
Q1 | $24.5K | Buy |
1,019
+292
| +40% | +$7.01K | ﹤0.01% | 3760 |
|
|
2022
Q4 | $14.2K | Buy |
727
+52
| +8% | +$1.01K | ﹤0.01% | 3895 |
|
|
2022
Q3 | $14K | Buy |
675
+107
| +19% | +$2.22K | ﹤0.01% | 3970 |
|
|
2022
Q2 | $11K | Sell |
568
-82
| -13% | -$1.59K | ﹤0.01% | 4090 |
|
|
2022
Q1 | $14K | Buy |
+650
| New | +$14K | ﹤0.01% | 4132 |
|
|
2021
Q3 | – | Sell |
-114,328
| Closed | -$1.98M | – | 4768 |
|
|
2021
Q2 | $1.98M | Hold |
114,328
| – | – | ﹤0.01% | 2552 |
|
|
2021
Q1 | $2.27M | Sell |
114,328
-44,900
| -28% | -$890K | ﹤0.01% | 2445 |
|
|
2020
Q4 | $2.78M | Sell |
159,228
-54,336
| -25% | -$949K | ﹤0.01% | 2326 |
|
|
2020
Q3 | $4.12M | Sell |
213,564
-21,436
| -9% | -$413K | ﹤0.01% | 2126 |
|
|
2020
Q2 | $4.57M | Hold |
235,000
| – | – | ﹤0.01% | 2079 |
|
|
2020
Q1 | $3.29M | Buy |
+235,000
| New | +$3.29M | ﹤0.01% | 2059 |
|